Aviceda Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Aviceda Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema (NCT06181227) | Aviceda Therapeutics, Inc. | 2023-11-30 |
| A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (NCT05839041) | Aviceda Therapeutics, Inc. | 2023-05-02 |
Track Aviceda Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.